谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Supplementary Figure 4 from Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245409 (XL765), a Novel, Orally Administered PI3K/mTOR Inhibitor in Patients with Advanced Solid Tumors

Kyriakos P. Papadopoulos,Josep Tabernero,Ben Markman,Amita Patnaik,Anthony W. Tolcher,José Baselga, Weiliang Shi,Coumaran Egile,Rodrigo Ruiz-Soto,A. Douglas Laird,Dale Miles,Patricia M. LoRusso

openalex（2023）

引用 0|浏览0
暂无评分
摘要
PDF file - 1779KB, Supplementary Figure 4. Effect of SAR245409 on Skin Lesions of a Ductal Breast Carcinoma Patient.
更多
查看译文
关键词
Cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要